Phenylketonuria (PKU) is a well-known genetic cause of mental retardation, affecting one in 10,000 to 20,000 live births (Stanbury, Wyndgaarden, Friedrickson, 1983). The disorder is the consequence of mutations in the gene that codes for the enzyme phenylalanine hydroxylase (PAH). This enzyme is essential for hydroxylation of dietary phenylalanine (Phe) to tyrosine in the liver (Güttler, Lou, 1986). Given normal intake of Phe, severe mental handicap results (Jervis, 1939; cited in Knox, 1972). For the past four decades, however, newborn screening programs have identified individuals with PKU (Knox, 1972) so that a diet low in Phe can be initiated early in life. If dietary treatment is begun early and controlled consistently during childhood, mental retardation is averted.
Even with early dietary treatment of PKU, research suggests that impairments in the intellectual, cognitive, and behavioral domains occur. For example, whereas early treatment appears to result in intellectual levels in the normal range, the intelligence quotient (IQ) scores of children with PKU often do not achieve the levels predicted from the IQ scores of unaffected parents and siblings (Williamson, Dobson, Koch, 1977). In addition, studies that have found that IQ declines with age during the school years suggest that such declines can be linked to elevated Phe caused by poor or absent dietary control (Waisbren, Schnell, Levy, 1980). Research in the 1970s and 1980s on the cognitive skills of early-treated children with PKU indicated a pattern of cognitive function characterized by intact speech and language skills but impaired visual-spatial, perceptual-motor, and problem-solving abilities (Welsh, Pennington, 2000). With regard to behavior, early-treated children do not present a consistent clinical profile; however, behavioral problems tend to cluster in the areas of hyperactivity, impulsivity, poor planning, and less task persistence (Welsh, Pennington, 2000).
Although the specific neuropathology of PKU has not been explicated fully, one hypothesis proposes that PKU produces a prefrontal cortex dysfunction (Chamove, Molinaro, 1978; Pennington, van Doorninck, McCabe, et al., 1985; Welsh, 1996), and several lines of evidence are consistent with this hypothesis. First, the biochemical alterations resulting from genetic mutation cause a disruption in catecholamine biosynthesis. One of these catecholamines, dopamine, is essential for prefrontal cortical function. There is empirical evidence of lower levels of central dopamine (McKean, 1972) and an inverse association between Phe levels and dopamine levels in individuals with PKU (Krause, Halminski, McDonald, et al., 1985). Impaired prefrontal cortical function due to diminished levels of dopamine is consistent with decades of cognitive and behavioral research demonstrating a particular profile of deficits in early-treated PKU. The profile includes lower nonverbal intelligence, impairments in novel problem-solving, and impulsive behavior lacking in planning and goal orientation. Moreover, studies designed to explore the prefrontal dysfunction model of PKU have found evidence of specific impairments in a cognitive domain (executive function) that has been linked to this brain region (Diamond, Prevor, Callender, et al., 1997; Welsh, Pennington, Ozonoff, et al., 1990).
Our current understanding of the intellectual, cognitive, and behavioral characteristics of early-treated PKU, as well as the efficacy of diverse dietary regimens with regard to these characteristics, is the product of several qualitative reviews (e.g., Waisbren, Schnell, Levy, 1980; Welsh, Pennington, 2000). In what follows, an alternative systematic and quantitative approach to reviewing the empirical research on PKU will be described, and its potential value for making sense of the vast literature on early-treated PKU will be discussed.
Glass (1976) developed and advocated an approach to research integration referred to as "meta-analysis." According to Glass, McGraw, and Smith (1981), "it is nothing more than the attitude of data analysis applied to quantitative summaries of individual experiments. By recording the properties of studies and their findings in quantitative terms, the meta-analysis of research invites one who would integrate numerous and diverse findings to apply the full power of statistical methods to the task. Thus, it is not a technique; rather, it is a perspective that uses many techniques of measurement and statistical analysis." Meta-analysis can also be viewed "as a more explicit approach to literature review, complementary to narrative review, not in opposition to it" (L’Abbe, Detsky, O’Rourke, 1987). Thus, meta-analysis does not exclude the need for traditional reviews. Rather, it should be viewed as a statistical tool to summarize research findings.
At a time of great proliferation in published scientific research, meta-analyses are a vital necessity. It has been estimated that general practice physicians would need to read 19 journal articles a day, 365 days a year, just to keep their knowledge current (Anonymous, 1995). Given this large volume of research to be assimilated, the narrative method of research review—that is, studies chronologically and/or categorically arranged and described—is inadequate by itself to summarize this accumulated research.
In other words, qualitative and quantitative reviews of the literature are complementary approaches to addressing research questions in a comprehensive and coherent way. The following characteristics of the empirical literature on early-treated PKU provide a particularly compelling argument for the use of meta-analysis:
The meta-analytic approach to the literature typically involves five stages: (1) formulation of the questions to be answered, or specific aims; (2) execution of a complete literature search; (3) collection, classification, and coding of studies meeting inclusion criteria; (4) application of statistical techniques for pooling and analyzing the compiled data; and (5) evaluation and interpretation of the results in a written report.
The meta-analytic approach to the literature on PKU for the Consensus Development Conference on PKU has two stages. Regarding stage one, the specific questions to be addressed are as follows:
For the purposes of this report, we have restricted our analysis to the following:
Screening of the 2,346 abstracts listed in the NLM bibliography is under way. It is estimated that approximately 200 of them will meet inclusion criteria. Our objective is to apply meta-analytic methodology to summarize what is known and, when possible, to arrive at clear, definitive answers to issues of intellectual, cognitive, and neuropsychological performance in individuals with early-treated PKU. The relation of Phe level, dietary control, dietary termination, and dietary reinstitution to behavioral outcomes will also be evaluated.
Back to Abstracts